XML 59 R39.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
6 Months Ended
Jan. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of stock-based awards outstanding by award type
As of January 31, 2025, the following stock-based awards, by award type, were outstanding:
 January 31, 2025
Stock options135,690 
Performance shares668,103 
RSUs, restricted stock, share units and other stock-based awards1,221,288 
Total2,025,081 
Stock-based compensation for awards detailing where recorded in Consolidated Statement of Operations
Stock-based compensation for awards issued is reflected in the following line items in our Condensed Consolidated Statements of Operations:
 Three months ended January 31,Six months ended January 31,
 2025202420252024
Cost of sales$96,000 131,000 $200,000 413,000 
Selling, general and administrative expenses1,014,000 1,991,000 1,000,000 4,167,000 
Research and development expenses60,000 67,000 125,000 254,000 
Stock-based compensation expense before income tax benefit1,170,000 2,189,000 1,325,000 4,834,000 
Estimated income tax benefit(244,000)(484,000)(264,000)(1,068,000)
Net stock-based compensation expense$926,000 1,705,000 $1,061,000 3,766,000 
Summary of stock-based compensation expense by award type
Stock-based compensation expense, by award type, is summarized as follows:
Three months ended January 31,Six months ended January 31,
2025202420252024
Stock options$3,000 12,000 $20,000 31,000 
Performance shares302,000 585,000 (95,000)942,000 
RSUs, restricted stock and share units850,000 1,566,000 1,371,000 3,810,000 
ESPP15,000 26,000 29,000 51,000 
Stock-based compensation expense before income tax benefit1,170,000 2,189,000 1,325,000 4,834,000 
Estimated income tax benefit(244,000)(484,000)(264,000)(1,068,000)
Net stock-based compensation expense$926,000 1,705,000 $1,061,000 3,766,000 
Summary of the Plan's activity relating to stock options
The following table summarizes the Plan's activity:
 Awards
(in Shares)
Weighted Average
Exercise Price
Weighted Average
Remaining Contractual
Term (Years)
Aggregate
Intrinsic Value
Outstanding at July 31, 2024141,190 $20.61   
Outstanding at October 31, 2024141,190 $20.61 
Expired/canceled(5,500)17.88   
Outstanding at January 31, 2025135,690 $20.72 3.95$— 
Exercisable at January 31, 2025128,440 $20.88 3.87$— 
Vested and expected to vest at January 31, 2025135,287 $20.73 3.95$— 
Summary of the Plan's activity relating to performance shares, RSUs, restricted stock and share units
The following table summarizes the Plan's activity relating to performance shares, RSUs, restricted stock, share units and other stock-based awards:
  Awards
(in Shares)
Weighted Average
Grant Date
Fair Value
Aggregate
Intrinsic Value
Outstanding at July 31, 2024 1,800,288 $10.61 
Granted 1,154,859 5.04 
Settled (204,292)11.26 
Canceled/Forfeited (128,892)10.61 
Outstanding at October 31, 2024 2,621,963 8.11 
Granted 489,191 3.63 
Settled (578,751)9.41 
Canceled/Forfeited (643,012)5.48 
Outstanding at January 31, 20251,889,391 $6.61 $3,779,000 
  
Vested at January 31, 2025 125,904 $13.09 $252,000 
  
Vested and expected to vest at January 31, 2025 1,811,411 $6.60 $3,623,000